低发病率环境中的耐药性结核性脑膜炎 (DR-TBM):两个病例和证据审查突出了临床管理中的关键进展和知识差距
Karol F Boschung1, Patrick H P Wong1,2, Denise Werry2
1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Open forum infectious diseases
|February 27, 2026
概括
两名患有耐药性结核性脑膜炎的患者使用新型口服多种药物治疗方案取得了很好的结果. 分子诊断和敏感性测试为治疗提供了信息,尽管里法抗性结果不一致.
科学领域:
- 传染性疾病 传染性疾病
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核性脑膜炎 (TBM) 是一种严重的结核病,患病率和死亡率很高.
- 耐药性TBM存在重大治疗挑战,特别是在资源丰富的环境中.
- 新型口服药物为耐药性TBM提供了新的治疗可能性.
研究的目的:
- 描述两名耐药性TBM患者的诊断和治疗方法.
- 评估分子诊断和敏感性测试在指导治疗中的有用性.
- 探索临床决策,当基因型和表型药物敏感性测试 (DST) 结果不一致时.
主要方法:
- 两名患有耐药性TBM的患者的病例报告.
- 治疗方案包括贝达奎林,一种尼特罗伊米达,环素和线索利德.
- 以分子诊断,DST和药理动力学数据为指导的药物选择.
主要成果:
- 这两位患者在>12个月的随访期间都取得了出色的临床结果.
- 副作用包括自杀念头,细胞衰竭,耳毒性和神经病变.
- 观察到基因型 (耐药) 和表型 (敏感) 里法 DST 之间的不一致.
结论:
- 新型口服药物可以有效治疗耐药性TBM.
- 分子诊断和全面的DST对于治疗选择至关重要.
- 管理基因型和表型DST之间的不一致性需要谨慎的临床判断.
相关概念视频
Pulmonary Tuberculosis V
688
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
688
Pulmonary Tuberculosis IV
575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Therapeutic Drug Monitoring: Affecting Factors
288
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288


